CAD 0.03
(25.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 60 Thousand CAD | -41.52% |
2022 | 5.55 Million CAD | -43.43% |
2021 | 9.81 Million CAD | 90.06% |
2020 | 5.16 Million CAD | 66.66% |
2019 | 3.09 Million CAD | 249.12% |
2018 | 887.23 Thousand CAD | -3.88% |
2017 | 923 Thousand CAD | 23.47% |
2016 | 747.57 Thousand CAD | -46.06% |
2015 | 1.38 Million CAD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 1.12 Million CAD | 12.0% |
2023 Q3 | 940 Thousand CAD | 24.17% |
2023 Q4 | 1 Million CAD | 7.23% |
2023 Q2 | 757 Thousand CAD | 18.1% |
2023 FY | 3.24 Million CAD | -41.52% |
2023 Q1 | 641 Thousand CAD | -55.14% |
2022 Q3 | 1.19 Million CAD | -33.13% |
2022 Q2 | 1.79 Million CAD | 57.71% |
2022 FY | 5.55 Million CAD | -43.43% |
2022 Q1 | 1.13 Million CAD | -51.97% |
2022 Q4 | 1.42 Million CAD | 19.38% |
2021 Q2 | 2.49 Million CAD | 21.03% |
2021 Q4 | 2.36 Million CAD | 15.38% |
2021 Q3 | 2.04 Million CAD | -18.01% |
2021 FY | 9.81 Million CAD | 90.06% |
2021 Q1 | 2.06 Million CAD | -37.95% |
2020 Q2 | 681.38 Thousand CAD | 17.86% |
2020 FY | 5.16 Million CAD | 66.66% |
2020 Q4 | 3.32 Million CAD | 492.21% |
2020 Q3 | 561.71 Thousand CAD | -17.56% |
2020 Q1 | 578.11 Thousand CAD | -58.04% |
2019 Q2 | 505.62 Thousand CAD | 40.83% |
2019 Q3 | 873.86 Thousand CAD | 72.83% |
2019 FY | 3.09 Million CAD | 249.12% |
2019 Q4 | 1.37 Million CAD | 57.66% |
2019 Q1 | 359.01 Thousand CAD | 0.0% |
2018 Q3 | 29 Thousand CAD | 0.0% |
2018 FY | 887.23 Thousand CAD | -3.88% |
2017 FY | 923 Thousand CAD | 23.47% |
2016 FY | 747.57 Thousand CAD | -46.06% |
2015 FY | 1.38 Million CAD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aion Therapeutic Inc. | 163.11 Thousand CAD | 63.217% |
Ayurcann Holdings Corp. | 11.71 Million CAD | 99.488% |
Blueberries Medical Corp. | 84.22 Thousand CAD | 28.762% |
The BC Bud Corporation | 1.28 Million CAD | 95.323% |
BioNxt Solutions Inc. | 6.73 Million CAD | 99.11% |
CordovaCann Corp. | 3.86 Million CAD | 98.446% |
Christina Lake Cannabis Corp. | 4.28 Million CAD | 98.599% |
Captor Capital Corp. | 16.28 Million CAD | 99.632% |
City View Green Holdings Inc. | 705.7 Thousand CAD | 91.498% |
1CM Inc. | 7.3 Million CAD | 99.179% |
Global Hemp Group Inc. | 551.7 Thousand CAD | 89.125% |
Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 98.752% |
IM Cannabis Corp. | 22.63 Million CAD | 99.735% |
Lobe Sciences Ltd. | 4.13 Million CAD | 98.548% |
Maple Leaf Green World Inc. | 392.21 Thousand CAD | 84.702% |
Nextleaf Solutions Ltd. | 1.76 Million CAD | 96.606% |
Ovation Science Inc. | 54.1 Thousand CAD | -10.906% |
Pharmadrug Inc. | 1.33 Million CAD | 95.506% |
Captiva Verde Wellness Corp. | 1.3 Million CAD | 95.404% |
RAMM Pharma Corp. | 7.48 Million CAD | 99.198% |
RIV Capital Inc. | 21.1 Million CAD | 99.716% |
Revive Therapeutics Ltd. | 3.28 Million CAD | 98.174% |
Red White & Bloom Brands Inc. | 37.75 Million CAD | 99.841% |
SLANG Worldwide Inc. | 24.6 Million CAD | 99.756% |
1933 Industries Inc. | 5.12 Million CAD | 98.829% |
Red Light Holland Corp. | 2.02 Million CAD | 97.03% |
Top Strike Resources Corp. | 3.63 Million CAD | 98.348% |
Xebra Brands Ltd. | -308.42 Thousand CAD | 119.454% |
Adastra Holdings Ltd. | 9.36 Million CAD | 99.359% |